We offer culturing of patient perirectal swabs for detection of carbapenemase producing organisms, including identification and determination of genes of drug resistance. Any isolates of interest can be further analyzed through whole genome sequencing.
Your clinical surveillance system has pinged! -ALERT-ertapenem nonsusceptible Escherichia coli in a dialysate fluid from a patient in the Surgical Intensive Care Unit.
Didn’t I get a similar alert earlier this month?
Your review of the EMR shows that in fact a surgical site infection with an Escherichia coli with Klebsiella pneumoniae carbapenemase in a different patient but in the same room.
You recently read the CDC’s online guide for Healthcare Environmental Infection Prevention. You know that there is current evidence that patients can be exposed to MDROs persisting in the sinks and toilets of healthcare facilities.
AMR Services, Inc. can provide interventions
- A point prevalence survey of CPO colonization in patients of the affected unit/s
Sampling and culture of the premise plumbing
Whole genome sequencing of recovered patient and environmental isolates with analysis of relatedness.
Consultation to mitigate transmission
HOW WE HELP
Request A CONSULTATION
Infection prevention groups can send us isolates (patient and/or environmental) and we utilize our advanced, high-quality laboratory services and analytics – including Whole Genome Sequencing (WGS) – to answer the following types of questions for you in a timely manner:
Are these organisms related?
Is this infection imported from outside our facility or acquired nosocomially? What is the potential role of the clinical environment?
Has this specific strain of pathogen been seen in our facility before? Is there an issue in our environment that we need to address?
How can we identify and manage point sources? How implement a surveillance program?